Swedish Orphan Biovitrum AB (SWTUY.PK) announced earnings for its fourth quarter that increased from the same period last year
The company's earnings came in at SEK1.397 billion, or SEK4.02 per share. This compares with SEK1.026 billion, or SEK2.99 per share, last year.
Excluding items, Swedish Orphan Biovitrum AB reported adjusted earnings of SEK3.98 per share for the period.
The company's revenue for the period rose 8.6% to SEK7.436 billion from SEK6.844 billion last year.
Swedish Orphan Biovitrum AB earnings at a glance (GAAP) :
-Earnings: SEK1.397 Bln. vs. SEK1.026 Bln. last year.-EPS: SEK4.02 vs. SEK2.99 last year.-Revenue: SEK7.436 Bln vs. SEK6.844 Bln last year.
Looking ahead, for the full-year 2025, the company expects its revenue to grow by a high single-digit percentage at CER, with adjusted EBITA margin to be in the mid-30s percentage of revenue.
For comments and feedback contact: editorial@rttnews.com
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.